Influence of interleukin-6 gene polymorphism on the efficacy of antiviral treatment in patients with chronic hepatitis C

Influence of interleukin-6 gene polymorphism on the efficacy of antiviral treatment in patients with chronic hepatitis C

Aim. The aim of the work was to determine the influence of interleukin-6 gene polymorphism on the effectiveness of antiviral therapy in patients with chronic hepatitis C. Materials and methods. A total of 83 patients with chronic hepatitis C (CHC). were included in the study. The efficacy of ther...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. Yu. Riabokon, K. V. Kalashnyk, O. V. Riabokon
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2019-02-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	chronic hepatitis C interleukin-6 genetic polymorphism antiviral agents
Online Access:	http://zmj.zsmu.edu.ua/article/view/155826/155858
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interaction of polymorphism of the interleukin-6 gene with immunological damages and their role in the development of mixed cryoglobulinemia in patients with chronic hepatitis C
by: K. V. Kalashnyk, et al.
Published: (2019-05-01)

Monitoring of patients with chronic hepatitis B without liver cirrhosis while determining the tactics of treatment
by: O. V. Riabokon, et al.
Published: (2018-09-01)

The role of interleukin-10 and its encoding gene polymorphism influence on the course of infections caused by varicella-zoster virus
by: N. V. Onishchenko, et al.
Published: (2020-02-01)

The role of interleukin-10 gene polymorphism (rs 1800872) in the course of herpes zoster in adults
by: N. V. Onishchenko, et al.
Published: (2018-12-01)

Single nucleotide polymorphisms of interleukins associated with hepatitis C virus infection in Egypt
by: Hany Khalil, et al.
Published: (2017-03-01)

THE ROLE OF INTERLEUKIN-6 GENE IN DEVELOPMENT OF IDIOPATHIC SICK SINUS SYNDROME
by: S. Yu. Nikulina, et al.
Published: (2016-10-01)

Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China?
by: Zhitao Wang, et al.
Published: (2025-07-01)

Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency
by: H. V. Venytska, et al.
Published: (2022-12-01)

Association between Allelic Variations of -174G/C Polymorphism of Interleukin-6 Gene and Chronic Kidney Disease-Mineral and Bone Disorder in Iraqi Patients
by: Mohanad Radeef
Published: (2020-12-01)

Interleukin-6 gene polymorphism in Saudi population with recurrent aphthous stomatitis
by: Samah Jameel Saeed Shabana, et al.
Published: (2021-12-01)

Interleukin-18 and its gene single nucleotide polymorphisms (SNPs) influence chronic hepatitis C progression
by: Ebada M Said, et al.
Published: (2018-04-01)

RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS
by: S. V. Zhavoronok, et al.
Published: (2018-10-01)

Association of CYP2E1*6 polymorphism of gene CYP2E1 with the risk and severity of chronic hepatitis C
by: V. V. Godovan, et al.
Published: (2014-06-01)

IMPACT OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C ON CYTOKINE SYNTHESIS AND HEPATIC FIBROSING PROCESSES
by: V. V. Shchekotov, et al.
Published: (2015-08-01)

THE EFFECT OF THE POLYMORPHISM OF THE INTERLEUKIN-28 GENE ON THE EFFECTIVENESS OF THE ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC EPSTEIN-BARR VIRUS INFECTION
by: O.G. Sorokina, et al.
Published: (2017-11-01)

Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C
by: O. V. Taratina, et al.
Published: (2014-08-01)

Frequency of Tumor Necrosis Factor-α, Interleukin-6, and Interleukin-10 Gene Polymorphisms in Mexican Patients with Diabetic Retinopathy and Diabetic Kidney Disease
by: Patricia Elvira Sánchez-Valencia, et al.
Published: (2025-04-01)

Clinical and pathogenetic value of immune disruptions in manifestation of mixed cryoglobulinemia in patients with chronic hepatitis C
by: O. O. Furyk, et al.
Published: (2018-04-01)

Efficacy of direct-acting antivirals in patients with hepatitis C virus-associated cryoglobulinemic vasculitis: Results of a long-term follow-up
by: S. V. Gavrisheva, et al.
Published: (2023-04-01)

The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature
by: Olga H. Orasan, et al.
Published: (2019-10-01)

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir
by: L. L. Popova, et al.
Published: (2018-12-01)

Momentum towards simplifying and expanding treatment for chronic hepatitis B: The body of evidence continues to grow: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
by: Robert J. Wong
Published: (2025-04-01)

The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6)
by: E. L. Nasonov, et al.
Published: (2022-11-01)

The interaction of morphological changes in the liver with the development of extrahepatic manifestations in patients with chronic hepatitis C
by: Yu. Yu. Riabokon, et al.
Published: (2018-04-01)

Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

Iron metabolism in chronic hepatitis C patients on antiviral treatment
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

Cardiometabolic risk factors and their relationship with the interleukin-6 receptor gene polymorphism (rs2228145) in patients with hypertrophic cardiomyopathy
by: T. G. Bezhanishvili, et al.
Published: (2020-11-01)

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
by: D. T. Abdurakhmanov
Published: (2009-02-01)

In silico Analysis of Human Endothelial Cell-specific Molecule 1 and Interleukin-6 Genetic Variants Involved in Coronary Artery Disease
by: Vineet Kulkarni, et al.
Published: (2024-12-01)

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents
by: N. V. Dunaeva, et al.
Published: (2018-12-01)

Health-related quality of life in patients with chronic hepatitis C during combined antiviral therapy
by: V. L. Rozina, et al.
Published: (2019-12-01)

ASSOCIATION OF rs4537545 (C>T) ALLELE POLYMORPHISM IN THE IL6R GENE WITH THE DEVELOPMENT OF RHEUMATOID ARTHRITIS
by: L. V. Topchieva, et al.
Published: (2020-06-01)

Relationships between HBeAg status of patients with chronic hepatitis B and changes in serum TNF-α, viral load and severity of morphological changes in the liver according to non-invasive tests
by: A. B. Khelemendyk, et al.
Published: (2021-05-01)

Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir +ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia
by: Simonović-Babić Jasmina, et al.
Published: (2019-01-01)

Efficacy of antiviral therapy in the treatment of severe forms of acute hepatitis B
by: E. V. Esaulenko, et al.
Published: (2016-02-01)

EVALUATION OF EFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C, CAUSED BY HCV GENOTYPE 6
by: D. A. Lioznov, et al.
Published: (2017-04-01)

Effects of antiviral therapy on reducing the risk of metabolic syndrome in patients with chronic hepatitis C
by: A. F. Novikova, et al.
Published: (2023-07-01)